Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
about
Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?Calcium Pyrophosphate Dihydrate Crystal Deposition Disease Simulating Osteoarthrosis of the Knee: A Case Report.Is there a relationship between solubility and resorbability of different calcium phosphate phases in vitro?Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.
P2860
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@ast
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@en
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@nl
type
label
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@ast
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@en
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@nl
prefLabel
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@ast
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@en
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@nl
P2093
P2860
P1476
Methotrexate in chronic-recurr ...... a randomized crossover trial.
@en
P2093
Anne Madigan
Axel Finckh
Daniel Van Linthoudt
David Neto
Diego Kyburz
Georges Rappoport
Geraldine M Mc Carthy
Marcel Weber
Pierre-Andre Guerne
Sandra Blumhardt
P2860
P2888
P356
10.1186/S13075-014-0458-4
P577
2014-10-15T00:00:00Z
P5875
P6179
1011910274